Background Immunotherapy has recently emerged as a treatment strategy which stimulates
the human immune system to kill tumor cells. Tumor immunotherapy is based on immune …

A substantial increase in colorectal cancer (CRC)–associated fatalities can be attributed to
tumor recurrence and multidrug resistance. Traditional treatment options, including radio …

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, with
clinical features of high metastatic potential, susceptibility to relapse, and poor prognosis …

The tumor microenvironment (TME) is a complex ecosystem of cells, signaling molecules,
and extracellular matrix components that profoundly influence cancer progression. Among …

This comprehensive review delves into the pivotal role of the tumor microenvironment (TME)
in cancer metastasis and therapeutic response, offering fresh insights into the intricate …

Navigating the intricate landscape of the tumor microenvironment (TME) unveils a pivotal
arena for cancer therapeutics, where cytokines and soluble mediators emerge as double …

This review focuses on the question of metabolic syndrome (MS) being a complex, but
essentially monophyletic, galaxy of associated diseases/disorders, or just a syndrome of …

Tumor tissue engineering holds great promise for replicating the physiological and
behavioral characteristics of tumors in vitro. Advances in this field have led to new …

Cancer-associated fibroblasts (CAFs) are key stromal cells in the tumor microenvironment
(TME) that critically contribute to cancer initiation and progression. In bladder cancer (BCa) …

Triple-negative breast cancer (TNBC) is a unique subtype of breast cancer characterized by
the lack of expression of the estrogen receptor, progesterone receptor, and human …